Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Mohamed Rawy: VTE Recommendations in Critical Care Patients
Mohamed Rawy/LinkedIn
Dec 29, 2025, 07:20

Mohamed Rawy: VTE Recommendations in Critical Care Patients

Mohamed Rawy, Hospital Pharmacist at Specialized Medical Center Hospital, shared on LinkedIn:

”From Paper to Patient … Episode 2 ( Part 1 )

Venous Thromboembolism recommendations in Critical Care Patients

  1. First, pharmacologic thromboprophylaxis remains the cornerstone of VTE prevention in ICU
  2. Second, LMWH is generally preferred over UFH since that LMWH probably reduces DVT compared to UFH
  3. The dosing definitions encom passed a range of doses rather than a single fixed dose , The authors suggested that using an intermediate dose
    of LMWH (e.g., enoxaparin 40–60 mg daily) was associated with a more favorable risk–benefit profile for VTE prevention compared to lower doses (e.g., < 40 mg daily, low-to-moderate certainty). Additionally, intermediate
    dose unfractionated heparin (total daily dose > 10,000 IU) was associated with a higher likelihood of major bleeding (low-to-moderate certainty)
  4. Fourth, when using LMWH for thromboprophylaxis, there is no need for routine monitoring of anti-Factor Xa (aFXa) levels. However, in selected patients, such as those with renal impairment, severe obesity or under
    weight, aFXa levels could be used to guide dosing
  5. Fifth, intermittent pneumatic compression should be used in patients who cannot receive pharmacologic thromboprophylaxis
  6. Sixth, there is no added benefit of routinely using intermittent pneumatic compression in patients already receiving appropriate pharmacologic thromboprophylaxis
  7. Seventh, intermittent pneumatic compression reduces the incidence of DVT when compared to graduated compression stockings (GCS) based on low certainty of evidence
  8. Eighth, intensivists should carefully balance the benefits of preventing VTE against the risk of bleeding
  9. Ninth, thromboprophylaxis in the ICU can be discontinued once the patient is no longer at high risk for VTE
  10. Tenth, certain clinical scenarios warrant specific VTE regimens, which should be guided by dedicated evidence-based references

Reference:
Springer 2025

Venous thromboprophylaxis in the ICU navigating evidence, risk, and practice gaps”

Mohamed Rawy: VTE Recommendations in Critical Care Patients

Stay updated with Hemostasis Today.

DVT Health Hematology Hemostasis Hemostasis Today ICU LMWH Medicine Mohamed Rawy Springer thrombosis UFH VTE
NewsFeed